EGFR and cancer: Furthermore, the cytotoxic effect of 188Re-liposome-Fcy-hEGF/5-FC was evaluated in EGFR-overexpressing cancer cells compared with the treatment of liposome-Fcy-hEGF/5-FC or 188Re-liposome-Fcy-hEGF alone.